| Factor Information | |
|---|---|
| Data ID | 3918 |
| Factor | ratio of B/A(peak concentration of dilution curve/amount of dye injected) |
| Description | The ratio of B/A in patients was lower than that in controls. |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | To access if dye dilution curve might provide information of significant clinical value in patients with suspected or demonstrated ab-normalities of the central circulatory pathway. |
| Conclusion | The ratio of B/A(peak concentration of dilution curve/amount of dye injected) in patients was lower than that in normal subjects. The dye injection method is of value in the differential diagnosis of acyanotic congenital heart diseases since it provides a simple and fairly reliable means of determining the presence or absence of a central circulatory shunt, of the magnitude usually associated with acyanotic congenital cardiac defects. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 1 |
| CHD Type | isolated CHD |
| CHD Subtype | ASD |
| Reference | |
|---|---|
| PMID | 13161119 |
| Year | 1954 |
| Title | Indicator-dilution curves in acyanotic congenital heart disease |
| Sample | ||
|---|---|---|
| Population | N/A | |
| Source | patients | |
| Region | Rochester, USA | |
| Method | Indicator-dilution curves /cuvette oximeter | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | ASD(Treatment) | controls(Control) |
| Number | 6 | 16 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 26±3(16-35) | 61±5(34-103) |
